Ace Investor Vijay Kedia’s Top 5 Holdings: ₹928 Cr Portfolio Across Auto, Pharma, Chemicals and Healthcare

Ace investor Vijay Kishanlal Kedia remains one of the most closely followed investors in the Indian stock market. According to the latest publicly available shareholding data for June 2026, Kedia publicly holds stakes in 23 companies, with his portfolio valued at around ₹1,474.19 crore. He began investing at the age of 19 and later founded Kedia Securities in 1992. Kedia is known for his long term investment approach and his SMILE framework, which stands for Small in size, Medium in experience, Large in aspiration and Extra large in market potential.

The latest portfolio data also shows several changes during June 2026. Kedia added Eimco Elecon (India) with a 1.45% stake and marginally increased his holding in Websol Energy Systems. He also reduced his stake in Innovators Facade Systems by 1.9% and Affordable Robotic & Automation by 0.3%. His five largest disclosed holdings are Atul Auto, Neuland Laboratories, Sudarshan Chemical Industries, Elecon Engineering and Yatharth Hospital, with a combined value of approximately ₹928.3 crore.

Vijay Kedia's Top 5 Holdings

Rank	Company	Holding Value	Holding	Shares Held
1	Atul Auto	₹334.7 crore	20.9%	58,02,017
2	Neuland Laboratories	₹297.1 crore	1.0%	1,30,000
3	Sudarshan Chemical Industries	₹114.0 crore	1.3%	10,00,000
4	Elecon Engineering	₹98.5 crore	1.0%	22,50,000
5	Yatharth Hospital	₹84.0 crore	1.0%	9,65,000
Total	Top 5 Holdings	₹928.3 crore

Atul Auto

Atul Auto is the largest disclosed position in Vijay Kedia's portfolio, with his stake valued at approximately ₹334.7 crore. Kedia holds 58.02 lakh shares, representing a 20.9% stake in the company. Atul Auto operates in the three wheeler automotive segment and manufactures vehicles for both passenger and goods transportation, including petrol, diesel, LPG and electric models along with spare parts and allied products.

As of August 7, 2026, Atul Auto had a market capitalisation of approximately ₹1,601 crore, while its share price stood at around ₹577. The stock traded at a P/E ratio of about 37 times, with a book value of ₹174, ROCE of 11.4% and ROE of 9.35%.

Atul Auto Financial Performance

Financial Metric	FY25	FY26
Sales	₹723 Cr	₹824 Cr
Operating Profit	₹52 Cr	₹84 Cr
Operating Margin	7%	10%
Profit Before Tax	₹27 Cr	₹57 Cr
Net Profit	₹18 Cr	₹43 Cr
EPS	₹7.79	₹15.23

Atul Auto's five year compounded profit growth stood at 47%, while three year profit growth was 125%. The stock recorded a one year price CAGR of approximately 33%. In the June 2026 quarter, revenue reached ₹241 crore, while net profit stood at ₹18 crore, compared with ₹153 crore revenue and ₹2 crore net profit in June 2025.

Neuland Laboratories

Neuland Laboratories is the second largest disclosed holding in Kedia's portfolio, with his stake valued at approximately ₹297.1 crore. He holds 1.30 lakh shares, representing a 1% stake in the company. Neuland Laboratories manufactures and sells bulk drugs for domestic and international markets, with its business including active pharmaceutical ingredients and other pharmaceutical operations.

As of August 7, 2026, Neuland Laboratories had a market capitalisation of approximately ₹29,323 crore, with the stock trading at around ₹22,855. Its P/E ratio stood at approximately 58.9 times, while ROCE was 26.5% and ROE was 21.2%.

Neuland Laboratories Financial Performance

Financial Metric	FY25	FY26
Sales	₹1,477 Cr	₹2,023 Cr
Operating Profit	₹331 Cr	₹580 Cr
Operating Margin	22%	29%
Profit Before Tax	₹346 Cr	₹489 Cr
Net Profit	₹260 Cr	₹364 Cr
EPS	₹202.74	₹283.71

Neuland Laboratories recorded three year compounded sales growth of 19% and five year profit growth of 39%. The stock recorded a five year price CAGR of around 70% and a three year price CAGR of approximately 79%. In June 2026, the company reported sales of ₹642 crore and net profit of ₹148 crore, compared with ₹293 crore sales and ₹14 crore net profit in June 2025.

Sudarshan Chemical Industries

Sudarshan Chemical Industries is the third largest holding in Kedia's disclosed portfolio, with his stake valued at approximately ₹114 crore. He owns 10 lakh shares, representing a 1.3% stake in the company. Sudarshan Chemical manufactures organic and inorganic pigments and effect pigments and has a significant presence in the global pigment market.

As of August 7, 2026, Sudarshan Chemical Industries had a market capitalisation of approximately ₹9,072 crore, while its stock price stood at around ₹1,140. The company traded at a P/E ratio of approximately 489 times, with ROCE at 5.46% and ROE at 0.54%.

Sudarshan Chemical Financial Performance

Financial Metric	FY25	FY26
Sales	₹3,346 Cr	₹9,787 Cr
Operating Profit	₹383 Cr	₹603 Cr
Operating Margin	11%	6%
Profit Before Tax	₹99 Cr	₹157 Cr
Net Profit	₹60 Cr	₹41 Cr
EPS	₹7.11	₹2.84

Sudarshan Chemical's revenue increased sharply in FY26, but profitability remained under pressure. Net profit declined from ₹60 crore to ₹41 crore, while operating margin fell from 11% to 6%. In June 2026, the company reported sales of ₹2,790 crore and net profit of ₹82 crore, compared with ₹2,507 crore sales and ₹55 crore net profit in June 2025.

Elecon Engineering

Elecon Engineering Company is the fourth largest holding in Kedia's portfolio by value, with his stake valued at approximately ₹98.5 crore. Kedia holds 22.5 lakh shares, representing around a 1% stake in the company. Elecon Engineering manufactures power transmission and material handling equipment and serves industries including power, cement, sugar and steel, with products ranging from gearboxes and couplings to planetary and marine gearboxes.

As of August 7, 2026, Elecon Engineering had a market capitalisation of approximately ₹9,825 crore, while its share price stood at around ₹438. The stock traded at a P/E ratio of approximately 32.5 times, with ROCE at 20.9% and ROE at 16.4%.

Elecon Engineering Financial Performance

Financial Metric	FY25	FY26
Sales	₹2,227 Cr	₹2,366 Cr
Operating Profit	₹548 Cr	₹523 Cr
Operating Margin	25%	22%
Profit Before Tax	₹537 Cr	₹454 Cr
Net Profit	₹415 Cr	₹341 Cr
EPS	₹18.50	₹15.20

Elecon Engineering recorded five year compounded sales growth of 18% and five year profit growth of approximately 44%. Its five year stock price CAGR stood at around 42%. In June 2026, the company reported sales of ₹521 crore and net profit of ₹70 crore.

Yatharth Hospital & Trauma Care Services

Yatharth Hospital & Trauma Care Services is the fifth largest disclosed holding in Kedia's portfolio, with his stake valued at approximately ₹84 crore. He holds 9.65 lakh shares, representing around a 1% stake in the company. Yatharth Hospital operates multi specialty and super specialty hospitals primarily across North India, with a hospital network offering more than 2,800 beds and multiple Centres of Excellence.

As of August 7, 2026, Yatharth Hospital had a market capitalisation of approximately ₹8,388 crore, while its share price stood at around ₹870. The stock traded at a P/E ratio of approximately 47.8 times, with ROCE at 12.4% and ROE at 10.4%.

Yatharth Hospital Financial Performance

Financial Metric	FY25	FY26
Sales	₹860 Cr	₹1,207 Cr
Operating Profit	₹225 Cr	₹292 Cr
Operating Margin	26%	24%
Profit Before Tax	₹172 Cr	₹224 Cr
Net Profit	₹131 Cr	₹170 Cr
EPS	₹13.55	₹18.20

Yatharth Hospital recorded five year compounded sales growth of 41% and five year profit growth of 57%. Its one year stock price CAGR stood at approximately 23%. In June 2026, revenue reached ₹342 crore and net profit stood at ₹45 crore, compared with ₹258 crore revenue and ₹42 crore net profit in June 2025.

Vijay Kedia Portfolio Changes in June 2026

Action	Company	Change
New Buy	Eimco Elecon (India)	Added 1.45% stake
Incremental Buy	Websol Energy Systems	Increased by 0.08%
Partial Exit	Innovators Facade Systems	Reduced by 1.9%
Partial Exit	Affordable Robotic & Automation	Reduced by 0.3%

The June 2026 portfolio data shows that Kedia continued to make selective changes to his holdings. He added a new position in Eimco Elecon and increased his stake in Websol Energy Systems, while trimming positions in Innovators Facade Systems and Affordable Robotic & Automation.

Vijay Kedia's Top Holdings: Key Takeaways

Vijay Kedia's publicly disclosed portfolio was valued at approximately ₹1,474.19 crore based on the June 2026 shareholding data. His five largest disclosed holdings were worth around ₹928.3 crore, with Atul Auto accounting for the largest position by value and ownership percentage.

The portfolio provides exposure to automobiles, pharmaceuticals, chemicals, industrial engineering and healthcare. While the financial performance of these companies varies significantly, the latest data shows strong growth in several of Kedia's major holdings, particularly Neuland Laboratories, Atul Auto and Yatharth Hospital.

The portfolio figures, shareholding data, stock prices and financial information in this article are based on the data provided and may change with subsequent exchange filings and market movements. Portfolio holdings should not be considered investment recommendations.